Psychotropic Drug Use Tied to Dementia

Older adults taking psychotropic drugs before contracting COVID-19 are at increased risk of dementia in the year following the illness, from a study published 18 March 2022.

Results from this large study of more than 1700 patients who had been hospitalized with COVID showed a greater than twofold increased risk for post-COVID dementia in those taking antipsychotics and mood stabilizers/anticonvulsants.

The study concludes: “In this cohort study of older adults hospitalized with COVID-19 at a large health system in New York, exposure to pre-COVID psychotropic medications was associated with greater 1-year incidence of post-COVID dementia.”

The psychiatric community continues to find that there are great liabilities to the use of psychiatric drugs, yet they continue to prescribe them.

How did psychotropic drugs, with no target illness, no known curative powers and a long and extensive list of harmful side effects, become the go-to treatment for every kind of psychological distress? And how did the psychiatrists espousing these drugs come to dominate the field of mental treatment? We think you deserve to know the truth.

It’s the story of big money — drugs that fuel a $330 billion psychiatric industry, without a single cure. The cost in human terms is even greater — these drugs now kill an estimated 42,000 people every year. And the death count keeps rising.

Psychiatry is probably the single most destructive force that has affected society within the last 60 years.” [The late Dr. Thomas Szasz, Professor of Psychiatry Emeritus]

Watch the CCHR documentary “The Marketing of Madness — Are We All Insane?” and find out what you can do about this.

Marketing of Madness
Marketing of Madness

This entry was posted in Big Muddy River Newsletter and tagged , . Bookmark the permalink.